Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 11/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3396650 | 0.82 | — | — | |
| SCHEMBL3072520 | 0.78 | FDPS (0.37) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL28581939 | 0.78 | GGPS1 (0.41) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL22040406 | 0.76 | GGPS1 (0.40) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL18456753 | 0.73 | FDPS (0.45) | FDPSGGPS1SMPD1 | |
| SCHEMBL4957018 | 0.73 | FDPS (0.33) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL2108808 | 0.72 | FDPS (0.39) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL4863854 | 0.71 | FDPS (0.35) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL4863856 | 0.71 | FDPS (0.35) | FDPSGGPS1SMPD1CES2LPAR1 | |
| SCHEMBL14743308 | 0.71 | FDPS (0.36) | FDPSGGPS1SMPD1CES2LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8314051-B2 | Method of preparing 1-methylcyclopropene and applying the same to plants | ERUM BIOTECHNOLOGIES INC. (KR) | 2012-11-20 | — | — | US | disclosed |
| US-20100076242-A1 | METHOD OF PREPARING 1-METHYLCYCLOPROPENE AND APPLYING THE SAME TO PLANTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076242-A1 | METHOD OF PREPARING 1-METHYLCYCLOPROPENE AND APPLYING THE SAME TO PLANTS | CHRM1, EMC1, CHRM2 | FDPS 199/4885GGPS1 240/4885SMPD1 438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.